Key facts
- GO-Pen’s last known valuation is $10.7M (Jun 2025).
- It has raised $5.0M; the latest was Angel (individual) ($910K) in Jun 2025.
- Notable investors include European Innovation Council, InnoFounder, DCB Innovation, Danish Tech Challenge.
- Status: Privately Held (backing).
- ·The complete investor list — 4 names
- ·Watchlist + deal alerts for GO-Pen
- ·The full record, as it builds
Funding rounds
No funding rounds for GO-Pen are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About GO-Pen
Manufacturer of a reusable insulin delivery pen intended to improve access to accurate insulin administration. The company offers a user-filled cartridge compatible with standard vials, durable multi-year construction, and controlled dose adjustment mechanisms, enabling individuals with diabetes to manage treatment with enhanced reliability at costs comparable to traditional injection methods.
- Sector
- Healthcare
- HQ
- Lyngby, Denmark
- Founded
- 2019
- Employees
- 11
- Website
- go-pen.com/
- Ownership
- Privately Held (backing)
GO-Pen doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in GO-Pen shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on GO-Pen in its N-PORT filings yet. We sweep new filings monthly.